Global Infertility 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR112403475

Publication Date:

November 28, 2024

Pages:

107

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Infertility market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.
Estimates from 1997 suggest that worldwide about five percent of all heterosexual couples have an unresolved problem with infertility. Many more couples, however, experience involuntary childlessness for at least one year: estimates range from 12% to 28%. 20-30% of infertility cases are due to male infertility, 20-35% are due to female infertility, and 25-40% are due to combined problems in both parts. In 10-20% of cases, no cause is found.
The report includes an overview of the development of the Infertility industry chain, the market status of Male (Assisted Reproductive Technology (ART), Artificial Insemination), Female (Assisted Reproductive Technology (ART), Artificial Insemination), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Infertility.
Regionally, the report analyzes the Infertility markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Infertility market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Infertility market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Infertility industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Assisted Reproductive Technology (ART), Artificial Insemination).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Infertility market.
Regional Analysis: The report involves examining the Infertility market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Infertility market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Infertility:
Company Analysis: Report covers individual Infertility players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Infertility This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Male, Female).
Technology Analysis: Report covers specific technologies relevant to Infertility. It assesses the current state, advancements, and potential future developments in Infertility areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Infertility market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Infertility market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Assisted Reproductive Technology (ART)
Artificial Insemination
Fertility Surgeries
麻豆原创 segment by Application
Male
Female
麻豆原创 segment by players, this report covers
The Cooper Companies
Cook Group
Thermo Fisher Scientific
Vitrolife
Esco Micro
Genea
Irvine Scientific
Ivftech
The Baker Company
Kitazato
Rinovum Women鈥檚 Health
Rocket Medical
Ihmedical
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infertility product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infertility, with revenue, gross margin and global market share of Infertility from 2019 to 2024.
Chapter 3, the Infertility competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Infertility market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infertility.
Chapter 13, to describe Infertility research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Infertility
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Infertility by Type
1.3.1 Overview: Global Infertility 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Infertility Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Assisted Reproductive Technology (ART)
1.3.4 Artificial Insemination
1.3.5 Fertility Surgeries
1.4 Global Infertility 麻豆原创 by Application
1.4.1 Overview: Global Infertility 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Male
1.4.3 Female
1.5 Global Infertility 麻豆原创 Size & Forecast
1.6 Global Infertility 麻豆原创 Size and Forecast by Region
1.6.1 Global Infertility 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Infertility 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Infertility 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Infertility 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Infertility 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Infertility 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Infertility 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 The Cooper Companies
2.1.1 The Cooper Companies Details
2.1.2 The Cooper Companies Major Business
2.1.3 The Cooper Companies Infertility Product and Solutions
2.1.4 The Cooper Companies Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 The Cooper Companies Recent Developments and Future Plans
2.2 Cook Group
2.2.1 Cook Group Details
2.2.2 Cook Group Major Business
2.2.3 Cook Group Infertility Product and Solutions
2.2.4 Cook Group Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Cook Group Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Infertility Product and Solutions
2.3.4 Thermo Fisher Scientific Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Vitrolife
2.4.1 Vitrolife Details
2.4.2 Vitrolife Major Business
2.4.3 Vitrolife Infertility Product and Solutions
2.4.4 Vitrolife Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Vitrolife Recent Developments and Future Plans
2.5 Esco Micro
2.5.1 Esco Micro Details
2.5.2 Esco Micro Major Business
2.5.3 Esco Micro Infertility Product and Solutions
2.5.4 Esco Micro Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Esco Micro Recent Developments and Future Plans
2.6 Genea
2.6.1 Genea Details
2.6.2 Genea Major Business
2.6.3 Genea Infertility Product and Solutions
2.6.4 Genea Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Genea Recent Developments and Future Plans
2.7 Irvine Scientific
2.7.1 Irvine Scientific Details
2.7.2 Irvine Scientific Major Business
2.7.3 Irvine Scientific Infertility Product and Solutions
2.7.4 Irvine Scientific Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Irvine Scientific Recent Developments and Future Plans
2.8 Ivftech
2.8.1 Ivftech Details
2.8.2 Ivftech Major Business
2.8.3 Ivftech Infertility Product and Solutions
2.8.4 Ivftech Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Ivftech Recent Developments and Future Plans
2.9 The Baker Company
2.9.1 The Baker Company Details
2.9.2 The Baker Company Major Business
2.9.3 The Baker Company Infertility Product and Solutions
2.9.4 The Baker Company Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 The Baker Company Recent Developments and Future Plans
2.10 Kitazato
2.10.1 Kitazato Details
2.10.2 Kitazato Major Business
2.10.3 Kitazato Infertility Product and Solutions
2.10.4 Kitazato Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Kitazato Recent Developments and Future Plans
2.11 Rinovum Women鈥檚 Health
2.11.1 Rinovum Women鈥檚 Health Details
2.11.2 Rinovum Women鈥檚 Health Major Business
2.11.3 Rinovum Women鈥檚 Health Infertility Product and Solutions
2.11.4 Rinovum Women鈥檚 Health Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Rinovum Women鈥檚 Health Recent Developments and Future Plans
2.12 Rocket Medical
2.12.1 Rocket Medical Details
2.12.2 Rocket Medical Major Business
2.12.3 Rocket Medical Infertility Product and Solutions
2.12.4 Rocket Medical Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Rocket Medical Recent Developments and Future Plans
2.13 Ihmedical
2.13.1 Ihmedical Details
2.13.2 Ihmedical Major Business
2.13.3 Ihmedical Infertility Product and Solutions
2.13.4 Ihmedical Infertility Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Ihmedical Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Infertility Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Infertility by Company Revenue
3.2.2 Top 3 Infertility Players 麻豆原创 Share in 2023
3.2.3 Top 6 Infertility Players 麻豆原创 Share in 2023
3.3 Infertility 麻豆原创: Overall Company Footprint Analysis
3.3.1 Infertility 麻豆原创: Region Footprint
3.3.2 Infertility 麻豆原创: Company Product Type Footprint
3.3.3 Infertility 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Infertility Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Infertility 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Infertility Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Infertility 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Infertility Consumption Value by Type (2019-2030)
6.2 North America Infertility Consumption Value by Application (2019-2030)
6.3 North America Infertility 麻豆原创 Size by Country
6.3.1 North America Infertility Consumption Value by Country (2019-2030)
6.3.2 United States Infertility 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Infertility 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Infertility 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Infertility Consumption Value by Type (2019-2030)
7.2 Europe Infertility Consumption Value by Application (2019-2030)
7.3 Europe Infertility 麻豆原创 Size by Country
7.3.1 Europe Infertility Consumption Value by Country (2019-2030)
7.3.2 Germany Infertility 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Infertility 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Infertility 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Infertility 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Infertility 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Infertility Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Infertility Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Infertility 麻豆原创 Size by Region
8.3.1 Asia-Pacific Infertility Consumption Value by Region (2019-2030)
8.3.2 China Infertility 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Infertility 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Infertility 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Infertility 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Infertility 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Infertility 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Infertility Consumption Value by Type (2019-2030)
9.2 South America Infertility Consumption Value by Application (2019-2030)
9.3 South America Infertility 麻豆原创 Size by Country
9.3.1 South America Infertility Consumption Value by Country (2019-2030)
9.3.2 Brazil Infertility 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Infertility 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Infertility Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Infertility Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Infertility 麻豆原创 Size by Country
10.3.1 Middle East & Africa Infertility Consumption Value by Country (2019-2030)
10.3.2 Turkey Infertility 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Infertility 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Infertility 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Infertility 麻豆原创 Drivers
11.2 Infertility 麻豆原创 Restraints
11.3 Infertility Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Infertility Industry Chain
12.2 Infertility Upstream Analysis
12.3 Infertility Midstream Analysis
12.4 Infertility Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

The Cooper Companies
Cook Group
Thermo Fisher Scientific
Vitrolife
Esco Micro
Genea
Irvine Scientific
Ivftech
The Baker Company
Kitazato
Rinovum Women鈥檚 Health
Rocket Medical
Ihmedical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.